TD Cowen analyst Charles Rhyee raised the firm’s price target on Cardinal Health (CAH) to $225 from $183 and keeps a Buy rating on the shares. The firm update their estimates following a F1Q26 where the company raised its adj. EPS guide, Pharma guide, and Other AOI guide.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health Reports Strong Earnings and Raises Guidance
- Cardinal Health price target raised to $220 from $190 at Evercore ISI
- Cardinal Health price target raised to $220 from $185 at UBS
- Cardinal Health price target raised to $232 from $208 at Baird
- Cardinal Health price target raised to $190 from $165 at Citi